Looks like you clickedhttps://www.urotoday.com/conference-highlights/esmo-2023/esmo-2023-prostate-cancer/147459-esmo-2023-enza-p-anzup-1901-enzalutamide-and-177lu-psma-617-in-poor-risk-metastatic-castration-resistant-prostate-cancer-mcrpc-a-randomized-phase-2-trial.html
If you do not want to visit that page, you can close this browser tab.
